logo-loader
viewBed Bath & Beyond Inc.

Bed Bath & Beyond stock slides on mixed 4Q and annual results

The home goods retailer beat expectations on earnings and met on revenue, but annual sales numbers disappointed

Bed Bath & Beyond storefront
The New Jersey-based retailer saw its 2018 annual sales come in at $12.03 billion, down from $12.35 billion in 2017

Bed Bath & Beyond Inc (NASDAQ:BBBY) shares slipped after the company beat analyst expectations late Wednesday for its fiscal fourth-quarter earnings results, however, posted its first annual sales decline in almost three decades.

Shares of the home goods retailer sank 8.8% to $17.71. 

In the fourth quarter, ended March 2, 2019, the company reported a net loss of $253.8 million, or $1.92 per diluted share, which included a non-cash goodwill and impairments charge, compared with $194 million, or $1.41 per diluted share, for the fiscal 2017 fourth quarter. 

Excluding the non-cash impairments charge, the home goods retailer reported net income of $158.8 million, or $1.20 per share, beating analyst estimates of $1.11 per share.

READ: Bed Bath & Beyond beats on 3Q earnings; shares jump in after-hours trading

For its fourth quarter revenue, Bed Bath & Beyond reported revenue of $3.3 billion, a decrease of approximately 11.0% compared to the prior year period, however, it met Street expectations of $3.3 billion. 

The company noted the drop was "primarily due to one less week in the quarter compared to fourteen weeks in fiscal 2017 and a shift in the calendar, moving the post-Thanksgiving holiday sales week out of the fourth quarter."

The company reported its same-store sales, which measures the company's existing stores that have operated for more than one year, fell 1.4%. Comparable sales, a closely watched figure in retail, dropped 1.1%. 

Annual sales down

Sales for the year were $12.03 billion, down from $12.35 billion a year earlier. 

"During the fourth quarter and throughout fiscal 2018, we have been driving significant foundational change across our business," said CEO Steven Temares in a statement. "The pace of our transformation accelerated during fiscal 2018."

Investors weren't happy. Legion Partners, Macellum Advisors and Ancora Advisors released a group statement Thursday calling for new leadership. 

"Under CEO Steven Temares’ direction, the company has fallen far behind retail peers and the operating deterioration is accelerating," the companies said. 

The group was also displeased to learn that the retailer proposed reducing coupons in order to increase profits. 

The retailer operates a chain of home goods stores in the US and Canada, including namesake Bed Bath and Beyond, buybuy BABY, Christmas Tree Shops and Harmon Face Values.

Contact Andrew Kessel at [email protected]

Follow him on Twitter @andrew_kessel

Quick facts: Bed Bath & Beyond Inc.

Price: 13.5 USD

NASDAQ:BBBY
Market: NASDAQ
Market Cap: $1.71 billion
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

VolitionRx records first revenues from research kits and strengthens balance...

VolitionRx Limited's (NYSEAMERICAN:VNRX) Cameron Reynolds talks Proactive London's Andrew Scott through the firm's third quarter update. He says excellent progress has been made on platform development - Nu.Q Capture, Nu.Q Vet and its colorectal cancer and lung cancer trials. Volition also...

28 minutes ago

2 min read